Skip to content

Development of Countermeasures Against Adverse Metabolic Effects of Shift Work

Development of Countermeasures Against Adverse Metabolic Effects of Shift Work

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02291952
Enrollment
20
Registered
2014-11-17
Start date
2015-03-19
Completion date
2018-08-29
Last updated
2020-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Dysregulation

Keywords

Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian

Brief summary

The goal of this application is to determine whether changing the timing of food intake prevents the adverse metabolic effects of circadian misalignment.

Detailed description

Shift work is associated with circadian misalignment and an increased risk for the development diabetes, obesity, and cardiovascular disease. This research will determine whether changing the feeding schedule can prevent metabolic alterations that can lead to the abovementioned disorders. This research will provide mechanistic insight and may provide a novel therapeutic approach against the increased risk for diabetes, obesity, and cardiovascular disease among shift workers.

Interventions

BEHAVIORALMeal schedule

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18.5 and 29.9 kgm-2 * Healthy adults with regular sleep-wake timing * Non-smokers * Completion of medical and psychological screening tests * Able to spend 14 consecutive days in the sleep laboratory

Exclusion criteria

* BMI \<18.5 or \> 29.9 kgm-2 * History of neurological or psychiatric disorder * History of sleep disorder or regular use of sleep-promoting medication * Current prescription, herbal, or over-the-counter medication use * Traveling across 2 or more time zones within past 3 months * Donating blood within past 8 weeks * Worked night or rotating shift work within past 3 years * Hearing impairment * Drug or alcohol dependency

Design outcomes

Primary

MeasureTime frameDescription
Change in circadian profile of plasma insulin levelsDuring circadian alignment (Day 7) and circadian misalignment (Day 10-11)Frequent blood samples
Change in plasma leptin levels across sleep/wake cycleDuring circadian alignment (Day 7) and circadian misalignment (Day 10-11)Frequent blood samples
Change in circadian profile of plasma leptinDuring constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)Frequent blood samples
Change in glucose toleranceDuring circadian alignment (Day 7) and circadian misalignment (Day 10-11)Frequent blood samples before and after standardized meals
Change in circadian profile of plasma glucose levelsDuring circadian alignment (Day 7) and circadian misalignment (Day 10-11)Frequent blood samples
Change in plasma insulin levels after standardized test mealDuring circadian alignment (Day 7) and circadian misalignment (Day 10-11)Frequent blood samples before and after standardized meals

Secondary

MeasureTime frameDescription
Changes circadian rhythm in resting energy expenditureDuring constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)Indirect calorimetry
Change in hunger and appetite, mood, and cognitive performanceTests taken throughout the protocol, days 1-14Subjective hunger ratings and cognitive tests performed via computer interface
Changes in microbiota, gene expression, epigenetic or proteomic markerssamples taken during forced desychrony (days 7-11) and the constant routine protocols (days 3-4 and 11-13)Frequent blood samples and saliva samples
Changes in sleepsleep periods following day 1, days 6-7 and days 10-11Polysomnography
o Change in circadian phase markers, such as from core body temperature, melatonin, and cortisolCore temperature and frequent blood samplesCore temperature sensor throughout protocol, days 1-14. Frequent blood samples during constant routine before forced desynchrony (Days 3-4) and constant routine after forced desynchrony (Days 12-13)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026